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The present study examines whether gonadotropins are involved in the regulation of ovarian 
GnRH gene expression and how ovarian GnRH gene expression temporalJy correlates with 
alterations in hypothalamic GnRH, pituitary LH~ gene expression in respons to gonadotropins. 
Hypothalamic and ovarian GnRH mRNA and pituitary LH~ mRNA levels were determined 
by respective RNA-blot hybridizations, and ovarian GnRH and estradiol contents and serum 
LH levels were measured by respective radioimmunoassays. Three animal models such as 1) 
PMSG-treated, 2) PMSG and heG-treated immature rats and 3) proestrous stage of adult 
rats were used. Immature rats (25-days old) were administered with PMSG (10 iu) at 10:00 
hand 48 h later with heG (10 iu) to induce ovulation. In the PMSG-injected model, hypothala-
mic GnRH mRNA levels were markedly augmented about 9-fold at 50 h, and pituitary LH 
mRNA 3-fold at 52 h after PMSG administration. Serum LH levels were increased to the 
preovulatory surge levels at 56 h, and ovarian GnRH mRNA levels were augmented 4-fold 
at 60 h after PMSG injection. Administration of heG also induced a marked enhancement 
in ovarian GnRH mRNA levels in comparison to the values shown in both intact and PMSG-
treated rats at 52 hand 54 h, respectively. In the proestrous stage of normal adult rats, 
pituitary LH~ mRNA levels were peaked at 16:00 h. The preovulatory LH surge was evident 
at 4 h before increment in ovarian GnRH mRNA levels as shown in PMSG-treated rats. 
The present study clearly showed the sequential increase in hypothalamic GnRH mRNA, pitui-
tary LH~ mRNA and ovarian GnRH mRNA levels, indicating that ovarian GnRH may play 
a possible role in the control of follicular maturation and the ovulation process. 
T he mammalian ovary is a highly heterogenous o r-
gan composed of many functionally different cells in-
cluding granulosa, theca, interstitial and luteal cells, 
and oocyte. There is an unique spatial and temporal 
expression of a specific set of genes that orchestrates 
cell growth and diffe rentiation of these cell types 
which are regulated by hormones in the hypothala-
mic-pituitary-ovarian axis (H all et af., 1991). Numerous 
neuropeptides and growth factors are known to act 
as intraovarian mediators. For instance, GnRH exerts 
inhibitory and/or stimulatory effects on intraovarian 
function (Sha rper, 1982; H sueh et al., 1983). GnRH 
regulates the fo rmation of gonadotropin receptor 
(H sueh et al., 1983), and increases the biosynthesis of 
progesterone in the ovary (D avis et af., 1988). G nRH 
also stimulates maturation of oocytes (Hillensjo and 
LeM aire, 1980; D ekel et af. , 1985), and ovulation 
(Ekholm et af., 1981). 
G nRH or GnRH-like peptide is evidently present 
in the ovary of various species including cows, sheep, 
* To whom correspondence should be add ressed. 
hu mans and rats (Ying et aI., 1981; Aten et af., 1986; 
Ireland el al., 1988). Existence of the amplified GnRH 
transcript in the rat ovary was recently demontrated 
by a reverse transcription-polymerase chain reaction 
method (O ikawa et al., 1990; G oubach et aI., 1992; 
Bauer-Dantoi n ef at., 1993). Our laboratory also demo-
nstrated the c, i\ tence and localization of G nRH tran-
script and ih g:e ne products in the ovary using in 
situ hybridiza ti () n histochemistry and immunohisto-
chemistry (Park , 'f al., 1988; Choi et aI., 1990). It is, 
however, yet unk nown whether the ovarian G nRH 
gene expression is p hysiologically regulated by gona-
dotropins, although it can be hypothesized that the 
regulation of ovarian G nRH may be under the influe-
nce of hypothalamic-pitui tary-ovarian hormonal axis. 
The present study examines whether gonadotropins 
The abbreviations used are: PM SG, r regnant mare serum 
gonadotropins; hCG, human chorion ic gonadotropins; 
MOPS, 3-(n-morpholino)propanesul fo nic acid; CV, coefficie-
nts of variation; LSD, least significa nce difference; tPA, ti-
ssue plasminogen activator. 
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are involved in the regulation of ovarian GnRH gene 
expression and how ovarian GnRH gene expression 
temporally correlates with alterations in hypothalamic 
GnRH and pituitary LHa gene expression in response 
to gonadotropins. Since administration of pregnant 
mare serum gonadotropins (PMSG) to immature fe-
male rats resulted in the stimulation of follicular ma-
turation and endogenous preovulatory-like LH surge 
(Bahr and Ben-Jonathan, 1981), the immature female 
rats administered with PMSG and/or human chorio-
nic gonadotropins (hCG) were used as a model system 
in the present study. 
Materials and Methods 
Animals 
Immature (25 days old) and adult female (2-3 mon-
ths old) Sprague-Dawley rats (Seoul National Univer-
sity .-}nimal Breeding Center, Seoul, Korea) were allow-
ed ad libitum to water and food and maintained un-
der 14 h light, 10 h dark conditions (light on 06:00). 
Twenty five-day-old rats were ip administered with 
either 10 iu PMSG (Sigma) alone or 10 iu PMSG + 10 
iu hCG (Sigma). hCG was administrated 48 h after 
PMSG. In the adult rats, the estrous cycle was moni-
tored by a daily vaginal smear procedure and those 
rats showing at least two consecutive 4-day cycles were 
used in the present study. After decapitation, ovaries, 
pituitaries and hypothalamic tissues were removed and 
stored at - 70 °c until use. Serum was also collected 
from trunk blood and kept at -20 °c prior to assay. 
Preparation of the rat GnRH and LH {3 gene probes 
GnRH antisense RNA transcript or GnRH oligo-
mer were used as a hybridization probe. GnRH 
cDNA clone inserted into plasmid pGEM4 (a gift 
from Dr. Kelly Mayo, Northwestern University, Evan-
ston, Ill.) was linearized and transcribed using SP6 
RNA polymerase to specific activity (1.0 X 109 cpm) 
(Seong et ai., 1993). GnRH oligomer (3 '-CG/GTC/ 
GTG/ACC/AGG/ATNCCC/AAC/GCG/GGA-5'; 29 
mer) complementary to the sequence of the rat GnRH 
mRNA coding for amino acids - 1 to 9 of decapep-
tide (Adelman et ai., 1986) was 5' end-labeled with 
y-32P-ATP (SA.; 3,000 Ci/mmole, NEN) to specific 
activity (2.l X 108 cpm/50 pmole) (Lee et al., 1990). 
Rat LH cDNA probe (a gift from Dr. J. L. Roberts, 
Mt. Sinai, New York) was labeled by a random primer 
labelling method (Feinberg and Vogelstein, 1984). 
Total RNA preparation and RNA analysis 
Total RNAs from hypothalami, pituitaries and ova-
ries were extracted by an acid guanidium-phenol-chlo-
roform method (Chomczynski and Sacchi, 1987). 
GnRH mRNA levels in hypothalami and ovarian tis-
sues were determined by Northern blot analysis or 
slot blot hybridization as described previously (Kim 
et al., 1989; Lee et al., 1990; Seong et al., 1993). For 
Northern blot analysis, total RNAs (20 J..1g of each 
group) were dissolved and denatured in 50% forma-
mide, 7.4% formaldehyde, 20 mM 3-(n-morpholino) 
propanesulfonic acid (MOPS), 5 mM sodium acetate 
and 1 mM EDTA at 60 °c. RNA was then fractiona-
ted by size using electrophoresis on 1.2% agarose gel 
containing 6.4% formaldehyde and 20 mM MOPS 
(Sam brook et ai., 1989) and transferred to Nytran me-
mbrane (Schleicher & Schuell; 0.22 J..11Tl pore size). For 
slot blot hybridization, RNAs (10 J..1g of each group) 
were solubilized in buffer consisting of 7.4% formalde-
hyde and 6X SSe. Nytran fUters were prehybridized 
with 10 ml hybridization buffer for 3 h at room tem-
perature in a heat sealable plastic bag (Kapak) follo-
wed by hybridization at 62 °c overnight with a gentle 
shaking. Hybridization buffer for GnRH RNA blot 
hybridization consists of 2X SSC, 2X Denhardt's so-
lution, 150 J..1g/mI of denatured salmon sperm DNA 
and 200 J..1g/ml of yeast tRNA (Lee et ai., 1990). Follo-
wing hybridization, Nytran membranes were washed 
with 2X SSC at 62 t for 5 min and then three times 
with 2 X SSC at 52 t for 30 min each. LH mRNA 
levels in pituitary were determined by RNA blot hyb-
ridization at 42 °c for 16 h. The details for hybridiza-
tion procedure are described elsewhere (Tepper and 
Roberts, 1984). The fLlters were auto radiographed with 
X-ray fLlm (Kodak, X-Omat RP fUm) and the density 
of bands was quantitated by densitometric scanning 
(Transdyne General Corp.). Nytran membrane was re-
hybridized with an 18S rONA control probe. GnRH 
and LHa mRNA levels were normalized by 18S RNA 
control values and expressed as an arbitrary unit. 
Radioimmunoassays for GnRH. LH and 17 fJestradiol 
GnRH concentrations in ovarian extracts were 
measured in duplicate by a RIA procedure using 
Chen-Ramirez anti-GnRH antiserum (CRR-II-B-72) 
at a final dilution of 1 : 20,000 (Kim et at., 1989). Ova-
rian tissues were homogenized in 600 J..1l of O.l N HC1, 
neutralized with 10 N NaOH and centrifuged at 15,000 
X g for 20 min at 4 °c. Synthetic GnRH (Sigma) 
was used as radioiodination and a reference standards. 
The sensitivity at 80% binding was about 0.5 pg/tube. 
The intra- and interassay coefficients of variation (CV) 
were about 6 and 7%, respectively. Serum LH levels 
were measured by a double antibody RIA method 
using reagents supplied by the NIADDK rLH-I-5 and 
rLH-RD-2 were used as radioiodination and a refere-
nce standard, respectively. Anti-LH antiserum (anti-
rLH-S-6) was used at a final dilution of 1 : 1,000,000. 
The detection limit for the LH assay was 20 pg/tube 
and the intra- and interassay CV were 5.9 and 8.9%, 
respectively. The ovarian concentrations of 17~-estra­
diol were determined using reagents supplied by the 
WHO Matched Reagent Program. Labeled ligand was 
[2, 4, 6, 7, 16, 17-3HJ-estradiol (3.73 X 1011 dpm/ mole, 
NEN). The intra- and interassay CV were 9.6 and 4.1 
%, respectively. 
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Statistical analysis 
C hanges in G nRH a nd LH~ mRNA and serum 
LH levels were analyzed by a one way analysis of 
va riance (ANOY A). F isher's least significance differe-
nce (LSD) test was used for post-hoc comparison with 
P < 0.05 requi red for statistical significance. Student's 
t-test was also employed fo r a nalysis o f the differences 
in hypothalamic and ovarian GnRH contents between 
the control and PMSG-treated groups. 
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Figure 1. Effeet of PMSG on hypothalamic GnRH mRNA 
(upper panel), pituita ry LH~ mRNA (middle panel) and ova-
rian GnRH mRNA (lower panel) levels in the control and 
PMSG-treated rats. mRNA levels are expressed as an arbit-
rary unit (A.U.) and bar represents the mean (± S.E. ) of 
repeated experiments (n=3). *, vs the control and other time 
points (P<O.Ol ). 
Results 
Effect oj PMSG on hypothalamic GnRH, pituitary LHp 
and ovarian GnRH mRNA levels 
The validation of GnRH RNA blot hybridization 
was previously well documented (Kim et al. , 1989; Lee 
et al., 1990; Seong et al., 1993). The sizes of GnRH 
a nd LH~ mRNA were approximately 0.6 kb (Kim et 
al., 1989) and 0.72 kb (Tepper and Roberts, 1984) as 
shown previously. The time course changes in hypo-
thalamic GnRH, pituitary LH~ and ovari an GnRH 
mRNA levels were examined at 2 h intervals from 
50 h to 60 h a fter PMSG treatment. Fifty hours follo-
wing PMSG administration, hypothalamic GnRH 
mRNA levels we re marked ly augmented. Hypothala-
mic G nRH mRNA levels we re then dra matically de-
cl ined to the control value a nd remained uncha nged 
until 60 h (Fig. 1, upper p anel). Pituitary LH~ mRNA 
levels were significa ntly increased 2-fold a t 52 h after 
PMSG injection and then returned to the basal levels 
(Fig. 1, middle panel). Note that the peak of hypotha-
lamic GnRH mRNA levels was 2 h earlier than that 
of pituitary LH~ mRNA levels. Ovarian GnRH 
mRNA levels did not increase until 58 h after PMSG 
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Figure 2. Serum LH levels of control and PMSG-injected 
ra ts. Each point represents the mean S.E. (n=6- 11). *, vs 
other time points (P <O.05). 
Table 1. Effects of PMSG on ovarian GnRH and estradiol 
contents 
Time(h) after GnRH content Estradiol content 
injection control PMSG control PMSG 
24 ND 29.8± II ND 136.6± 19.0 
48 20.8 ± 3.1 64.9± 1.7" 19.5± 4.9 181.2± 38.3" 
56 8.5± 1.7 67.6± 7.5" l8.0± 3.9 287.8± 41.9" 
72 2.6± 0.6 4.2± 0.9 20.0± 3.2 111.7 ± 28.5" 
GnRH and estradiol contents represent the mean ± S.E. 
(pg/pair of ova ries and pmol/pair of ovaries, respectively). 
Experiments were repeated six to eight times. ND; not deter-
mined. "PMSG vs control: significantly (P<0.05) diffe rent. 
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Injection. Ovarian GnRH mRNA levels were signifi -
cantly higher by 6-fold than the control values at 60 
h following PMSG administration (Fig. 1, lower 
panel). Serum LH levels started to increase and rea-
ched a peak at 56 h and then declined to the control 
levels. Serum LH levels in the controls remained un-
changed throughout the period examined (Fig. 2). 
Effect oj PMSG on ovarian GnRH and estradiol 
contents 
Table 1 shows the stimulatory effects of PMSG on 
ovarian GnRH and estradiol contents. A similar pat-
tern of both GnRH and estradiol contents was obser-
ved with maximal values at 56 h after PMSG injec-
tion. While ovarian GnRH contents in the control 
group were endogenously fluctuated with a high level 
at 24 h, ovarian GnRH contents began to increase 
at 24 h, reached a peak at 56 h, and then returned 
to nadir levels at 72 h. Estradiol contents rose IS-fo ld 
and then rapidly decreased. 
Effect oj PMSG and hCG on hypothalamic GnRH, 
pituitary LHp and ovarian GnRH mRNA levels 
As shown in Figure 1, hypothalamic GnRH mRNA 
levels were markedly increased at 50 h after PMSG 
injection when compared to the control values. How-
ever, this increment was not observed at 50 hand 
even 52 h after administration of hCG to PMSG-pri -
med rats (Fig. 3, upper panel). Similarly, an increase 
in pituitary LH~ mRNA levels at 52 h post-PMSG 
injection was not observed in PMSG and hCG-injec-
ted rats (Fig. 3, middle panel). These data indicated 
that the animals had not been affected by the endoge-
nous LH surge and negative effects of hCG on hypo-
thalamic-pituitary neural circuitry. On the other hand, 
administration of hCG to PMSG-pretreated immature 
rats significantly enhanced ovarian GnRH mRNA le-
vels 4-fold at 2 h and about 7-fold at 4 h after hCG-
administration (Fig. 3, lower panel). 
Temporal changes in pituitary LHp mRNA, serum LH 
and ovarian GnRH mRNA levels during the proestrous 
stage in normal cycling rats 
The time course changes in LH~ mRNA levels 
during the proestrous stage were then examined. 
The pituitary LH~ mRNA levels were increased about 
2-fold at 16:00 h and then returned to the basal levels 
(Fig. 4, upper panel). At the same time, serum LH 
levels were significantly elevated by 16:00 h in the 
proestrous stage and then gradually decreased to the 
basal levels (Fig. 4, middle panel). Ovarian GnRH 
mRNA levels, however, were markedly increased at 
14:00 h as compared to those at 10:00 h, and remained 
at similar values until 18:00 h with a peak at 20:00 
h (Fig. 4, lower panel). Likewise, in the PMSG-injec-
ted immature rats, serum LH levels were elevated at 
16:00 h, 4 h before the peak of ovarian GnRH gene 
expression. 
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Figure 3. Effects of PMSG and hCG on hypothalamic 
GnRH mRNA (upper panel), pituitary LHB mRNA (middle 
panel) and ovarian GnRH mRNA (lower panel) levels. 
Fourth-eight hours after PMSG injection, animals were ad-
ministered with saline and 10 iu hCG, then sacrificed at 
indicated times. Bar represents the mean (± S.E.) of repeated 
experiments (n = 3). *, vs the control and PMSG-injected. 
group (P<O.OI). 
Discussion 
The present study provides evidence that there are 
temporal relationships between hypothalamic Gn RH, 
pituitary LH~ and ovarian GnRH gene expression in 
PMSG-treated rats. These data indicate that ovarian 
GnRH gene expression appears to be under the inf-
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panel), serum LH (middle panel) and ovarian GnRH 
mRNA levels (lower panel) during proestrous stage in nor-
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at 14:00 h were set to 1.0 A.U). Bar indicates the mean 
S.E. of repeated experiments (n =4). *, vs other time points 
(P± 0.01). 
luence of classical hypothalamic-pituitary-ovarian hor-
monal axis in the rat. In the endocrine axis, activation 
of hormonal genes, such as hypothalamic GnRH, 
pituitary LH and ovarian GnRH was sequentially oc-
curred in a well-ordered manner. The changes in ova-
rian GnRH and estradiol contents by PMSG also 
showed a similar pattern, indicating that ovarian 
GnRH is involved in ovarian steroidogenesis. It can 
be hypothesized that activation of ovarian GnRH 
gene expression in preovulatory follicles may require 
the endogenous LH surge. Administration of hCG to 
PMSG-treated rats suppressed hypothalamic GnRH 
and pituitary LH~ mRNA levels which were thought 
to be responsible for inducing the LH surge. It ap-
pears that there is a negative short-loop feedback of 
LH, which inhibited hypothalamic GnRH activity. 
During the proestrous stage of normal rats, ovarian 
GnRH production was significantly enhanced at 4 h 
after the preovulatory LH surge (Fig. 4). These results 
support the above notion. 
Hypothalamic GnRH is transported to pituitary go-
nadotropes through a specialized portal vessel and sti -
mulates the release of gonadotropins (FSH and LH) . 
Gonadotropins then regulate the production of ste-
roids which modulate ovarian functions, such as pro-
duction of intracellular proteins, cell proliferation and 
activation of steroidogenic enzymes. Several intraova-
rian regulators including GnRH can affect local cellu-
lar response and directly respond to gonadotropins 
(Tonetta and diZerega, 1989). Indeed, PMSG and/or 
hCG can stimulate ovarian inhibin (Davis et al., 1988), 
thymosin (Hall et al., 1991) and tissue plasminogen 
activator (tPA) (Ny et al., 1987; O'Connell et al., 1987). 
It has been known that PMSG is capable of inducing 
LH/hCG receptors in granulosa cells of preovulatory 
follicles (Richards et aI., 1989), and hCG exerts the 
LH-like effects on enhancing GnRH production in 
granulosa cells. The present study suggests that FSH 
may act as a primer and LH as a stimulator in ova-
rian GnRH gene expression. However, the possibility 
that FSH may have a direct stimulatory effect on 
GnRH production can not be excluded. 
Special notice has also taken of the regulatory me-
chanism(s) of oocyte maturation and ovulation. Since 
the preovulatory LH surge-like response is elicited by 
GnRH and its agonist (Hillensjo and LeMaire, 1980; 
Oekel et al., 1983), and, more importantly, the GnRH 
receptor is present in rat oocyte membrane (Oekel 
et al., 1988), it is possible to presume that there may 
be some common mechanism shared by GnRH and 
LH in the rat ovary (Oekel et al., 1985). Several lines 
of evidence suggest that tPA plays an important role 
in gonadotropins-induced ovulation process (Beers, 
1975; Reich et al., 1985). Gonadotropins stimulate tPA 
activity and the activity of this protease is temporally 
correlated with ovulation. GnRH is able to increase 
tPA activity and mRNA levels in cultured rat granu-
losa cells (Ny et al., 1987). It appears then that an 
increase in tPA may represent a common pathway 
in the mechanism of ovulation induced by LH/hCG 
or GnRH. Indeed, in the present study, hCG directly 
enhanced ovarian GnRH synthesis before ovulation. 
It is possible to presume that LH/hCG may increase 
ovarian GnRH which, in tum, may induce tPA and 
eventually ovulation. Further studies are necessary for 
elucidation of the precise molecular mechanism of 
ovulation. 
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